Recall Z-1107-2020— bioMerieux, Inc.

Class II · Terminated

Class II FDA medical device recall by bioMerieux, Inc., initiated 2019-12-10, terminated 2021-02-16. It names one FDA 510(k) clearance: K923122. Product: VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit. Reason: Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result..

Recalling firm
bioMerieux, Inc.
Classification
Class II
Status
Terminated
Initiated
2019-12-10
Terminated
2021-02-16
Firm location
Durham, NC, United States

510(k) clearances named in this recall

1 on FDA's record

K-numbers as listed on FDA's Recall Enterprise System record for this event (openFDA device/recall k_numbers). The recall may also cover devices cleared under other submissions not named here.

Product description

VIDAS Varicella Zoster IgG (VZG) antibody IVD, kit

Reason for recall

Two batches of VIDAS Varicella-Zoster IgG (VZG ref 30217) may yield an invalid calibration which may delay the patient's sample result or a valid calibration may lead to a false positive patient result.

Data sourced from openFDA. This site is unofficial and independent of the FDA.